F-star Therapeutics Inc.

NASDAQ: FSTX · Real-Time Price · USD
7.12
0.00 (0.00%)
At close: Mar 08, 2023, 10:00 PM

F-star Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Cash & Equivalents
78.55M
Short-Term Investments
n/a
Long-Term Investments
n/a
Other Long-Term Assets
451K
Receivables
2.31M
Inventory
-2.31M
Other Current Assets
6.19M
Total Current Assets
84.74M
Property-Plant & Equipment
4.17M
Goodwill & Intangibles
33.66M
Total Long-Term Assets
38.28M
Total Assets
123.02M
Account Payables
3.08M
Deferred Revenue
5.79M
Short-Term Debt
906K
Other Current Liabilities
2.36M
Total Current Liabilities
12.13M
Long-Term Debt
12.33M
Other Long-Term Liabilities
1.69M
Total Long-Term Liabilities
14.03M
Total Liabilities
26.16M
Total Debt
13.23M
Common Stock
2K
Retained Earnings
-78.45M
Comprehensive Income
-1.5M
Shareholders Equity
96.86M
Total Investments
n/a